Spots Global Cancer Trial Database for adult subependymal giant cell astrocytoma

Every month we try and update this database with for adult subependymal giant cell astrocytoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Everolimus in Treating Patients With Recurrent Low-Grade Glioma	NCT00823459	Adult Diffuse A... Adult Mixed Gli... Adult Oligodend... Adult Subependy... Recurrent Adult...	Everolimus Archival Tissue...	18 Years -	University of California, San Francisco
Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors	NCT00499798	Brain and Centr... Chemotherapeuti... Infertility		18 Years - 60 Years	Wake Forest University Health Sciences
Everolimus in Treating Patients With Recurrent Low-Grade Glioma	NCT00823459	Adult Diffuse A... Adult Mixed Gli... Adult Oligodend... Adult Subependy... Recurrent Adult...	Everolimus Archival Tissue...	18 Years -	University of California, San Francisco
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors	NCT00002647	Brain and Centr... Metastatic Canc...	verteporfin conventional su...	3 Years - 70 Years	National Cancer Institute (NCI)
Bevacizumab in Recurrent Grade II and III Glioma	NCT01164189	Central Nervous...	Bevacizumab Temozolomide	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Everolimus in Treating Patients With Recurrent Low-Grade Glioma	NCT00823459	Adult Diffuse A... Adult Mixed Gli... Adult Oligodend... Adult Subependy... Recurrent Adult...	Everolimus Archival Tissue...	18 Years -	University of California, San Francisco
Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma	NCT00401024	Brain and Centr...	imatinib mesyla... pharmacological... conventional su...	18 Years - 120 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas	NCT02175745	Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... Childhood High-... Childhood High-... Childhood Low-g... Childhood Low-g... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child...	18F-fluoro-dihy... Positron emissi... Computed tomogr... Magnetic resona...	16 Years -	Stanford University
Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors	NCT00541138	Brain and Centr... Metastatic Canc... Unspecified Adu...	carboplatin tamoxifen citra... topotecan hydro... pharmacological...	18 Years -	City of Hope Medical Center
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas	NCT00083096	Brain and Centr...	lonafarnib temozolomide	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma	NCT00999622	Brain and Centr... Infection	laboratory biom... questionnaire a...	18 Years -	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Bevacizumab in Recurrent Grade II and III Glioma	NCT01164189	Central Nervous...	Bevacizumab Temozolomide	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma	NCT01119599	Acoustic Schwan... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Craniopha... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade I M... Adult Grade II ... Adult Medullobl... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Papillary... Adult Pilocytic... Adult Pineal Gl... Adult Pineoblas... Adult Pineocyto... Adult Primary M... Adult Subependy... Adult Subependy... Adult Supratent... Malignant Adult...	3-Dimensional C... Gamma-Secretase... Intensity-Modul... Laboratory Biom... Pharmacological... Temozolomide Therapeutic Con...	19 Years -	National Cancer Institute (NCI)
Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma	NCT00112736	Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... Recurrent Adult...	erlotinib temsirolimus therapeutic con... laboratory biom... pharmacological...	18 Years -	National Cancer Institute (NCI)
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors	NCT00967200	Central Nervous...	laboratory biom... pharmacogenomic...	18 Years - 120 Years	University Hospital, Montpellier
Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma	NCT00999622	Brain and Centr... Infection	laboratory biom... questionnaire a...	18 Years -	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma	NCT00498927	Brain and Centr...	temozolomide protein express... reverse transcr... diagnostic labo... immunoenzyme te...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Study of Blood and Cheek Cell Samples From Patients With Glioma	NCT01009307	Brain and Centr...	polymorphism an... laboratory biom... medical chart r...	18 Years - 120 Years	University of California, San Francisco
Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors	NCT00541138	Brain and Centr... Metastatic Canc... Unspecified Adu...	carboplatin tamoxifen citra... topotecan hydro... pharmacological...	18 Years -	City of Hope Medical Center
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas	NCT02186509	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... Recurrent Adult...	Hyperfractionat... Stereotactic ra... Alisertib Quality-of-life...	18 Years -	Thomas Jefferson University
Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma	NCT00730613	Brain and Centr...	therapeutic aut... gene expression... laboratory biom...	18 Years - 70 Years	City of Hope Medical Center
Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma	NCT00509431	Brain and Centr...	Erlotinib + Sir...	18 Years -	Jonsson Comprehensive Cancer Center
Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment	NCT00544284	Brain and Centr... Lymphoma Metastatic Canc... Unspecified Adu...	bortezomib temozolomide pharmacological...	18 Years -	City of Hope Medical Center
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors	NCT02194452	Acoustic Schwan... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Craniopha... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade I M... Adult Grade II ... Adult Medullobl... Adult Meningeal... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Papillary... Adult Pilocytic... Adult Pineal Gl... Adult Pineoblas... Adult Pineocyto... Adult Subependy... Adult Subependy... Adult Supratent... Childhood Choro... Childhood Crani... Childhood Epend... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Low-g... Childhood Medul... Childhood Supra... Meningeal Melan... Newly Diagnosed... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child...	gallium Ga 68-e... positron emissi... computed tomogr... laboratory biom...	6 Months - 29 Years	University of Iowa
Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors	NCT00541138	Brain and Centr... Metastatic Canc... Unspecified Adu...	carboplatin tamoxifen citra... topotecan hydro... pharmacological...	18 Years -	City of Hope Medical Center
Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma	NCT00112736	Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... Recurrent Adult...	erlotinib temsirolimus therapeutic con... laboratory biom... pharmacological...	18 Years -	National Cancer Institute (NCI)
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas	NCT00083096	Brain and Centr...	lonafarnib temozolomide	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma	NCT00999622	Brain and Centr... Infection	laboratory biom... questionnaire a...	18 Years -	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Bevacizumab in Recurrent Grade II and III Glioma	NCT01164189	Central Nervous...	Bevacizumab Temozolomide	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: